We all may complain and wonder about the processes of the FDA, but when you read stories like this one, it does make you wonder about the research and development in other countries and how thorough the process is, this in light of all the contaminated milk products on the market as well coming from...
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
Posted to
The Medical Quack .... by Barbara Duck
on 10-06-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Education, FDA, Pharmaceuticals, Pharmacogenomics, DNA Testing
New marketing technique going on here, gets you to the website, but no mention of the drug name . This ranks right up there with the Placebo ads from the FDA for a fake blood pressure pill , and what website will it take you to? Is there any honestly or dignity left in advertising? ...
This article brings up a good point, when a patient has no other choices and the potential of a new drug could offer some relief, what is the verdict at this point? The FDA has turned it's way of thinking around now to being much more conservative on the drugs that are approved. Do the drug companies...
A new possible term in the world of Biotech, Biogenerics? We currently have Pharmacogenomics working and now perhaps an interest with the Generic Drug business investing in Biotech as well or perhaps the availability of a generic without a long patent protection period? I am not quite sure...
The center of the investigation is whether or not the proper amount of the active ingredient was contained in the product and if the shelf life had been properly labeled according to the standards set forth by the FDA. There are efforts being made to group together on inspections with other countries...
Probably not a bad idea to look in to who and where some of the outsource companies would be. In other words would the FDA be outsourcing to US companies or would these too be companies located in other countries? Would there be an exclusion for the same country to manufacture and also inspect...